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Abstract
Tinnitus is a heterogeneous disorder that causes significant impairment in
many patients. Treatment is elusive and there is a need for more compre-
hensive guidelines for diagnosis and management of tinnitus. However,
different standardization approaches should be differentiated according to
their specific purpose. Standardization of assessment methods and outcome
measurements are useful for the performance of clinical trials, for compar-
ison of results across centers, for clinic audits, and for epidemiological studies.
In contrast, clinical guidelines are the best approach for the standardization of
the clinical management of tinnitus patients. In the development of these
clinical guidelines, the heterogeneity of tinnitus should be considered. Tinnitus
can be a symptom of a severe underlying disease. Also, there are specific
subforms of tinnitus for which curative treatment options are available.
Therefore,medical diagnosis is necessarily the first step in tinnitusmanagement.
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Treatment guidelines should not be restricted to recommendations that
are supported by high-level evidence. They should also contain treatment
recommendations that have shown clinically highly relevant effects in case
series of specific tinnitus subgroups.
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Wewant to thank Hoare et al., to draw the attention to the important topic of
the current practice of tinnitus management and the need for evidence-based
patient management protocols. Tinnitus is a frequent disorder. About 15% of
the population is affected (Shargorodsky et al., 2010) and in about 10% of
them, tinnitus severely impairs the quality of life (Axelsson & Ringdahl,
1989). With an even higher prevalence of tinnitus in expanding demo-
graphics, including aging individuals and recent war veterans (Department
of Veterans Affairs, 2008; Henry, Dennis, & Schechter, 2005), efficient
management of tinnitus is of growing concern.
Despite its high prevalence, there are only few specialized treatment
centers, evidence levels for most diagnostic and therapeutic procedures are
relatively low, and the few existing recommendations for treatment are only
rarely fulfilled in clinical practice (Hoare, Gander, Collins, Smith, & Hall,
2010). Current diagnosis and treatment of tinnitus patients is highly variable
not only across and within disciplines (audiology, ENT, psychology/
psychiatry) but also across and within countries. We therefore agree with
Hoare et al. that there is an urgent need for more comprehensive guidelines
for diagnosis and management of tinnitus. At the same time, standards
should always be developed in order to reach a specific goal and therefore
we advocate that the claim for guidelines is differentiated from the standardi-
zation of assessmentmethods and also from systematic outcomemeasurement
for evaluating specific treatment procedures.
Clinical guidelines should provide orientation in the diagnosis and
therapy of the individual patient. A standardized core set of different instru-
ments for qualitative and quantitative assessment of different aspects of the
tinnitus of the patient can be useful in this context. However, the goal in this
case is an exact description of all clinical features of the tinnitus in a given
patient based on reliable and validated assessment instruments. In turn,
a good and reliable clinical characterization of the tinnitus is a prerequisite
for finding the exact diagnosis in each patient, which in a second step then
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enables to select the appropriate treatment. Thus, in a chronic patient with the
main complaint of tinnitus-related concentration difficulties, other assessment
instruments are appropriate than in a patient who is suffering from an acute
pulsatile tinnitus. Also, for the assessment of the outcome in the individual
patient, it is important whether the treatment resulted in improvement in those
aspects and symptoms, which were most relevant for the patient himself, sug-
gesting the need for individualized assessment. In contrast, standardized
assessment methods are needed for the comparison of results across centers,
for clinic audits, and for epidemiological studies. Finally, for the analysis of
efficacy of specific therapeutic approaches interventions, either clinical trials
or systematic clinical observations have to be performed, involving specific
therapeutic interventions and standardized tinnitus assessment at defined
time-points before, during, and after the intervention. We are well aware that
there may be some overlap between the different needs of standardization.
On the other hand, different approaches will be needed to fulfill the different
purposes of standardization. As an example, a specific standardized question-
naire canbeveryuseful in thecontext ofdiagnostic assessment but inappropriate
for the use as outcome measurement (Meikle et al., 2007).
The Tinnitus Research Initiative (TRI) has adopted different strategies
for improving standards of both clinical management and clinical research.
These activities started with a consensus for trial methodology. There was
consensus among experts that there exist several validated Tinnitus
Questionnaires and that one of these should be used as primary outcomemea-
surement in clinical trials. The additional use of the THI was recommended
in order to enable comparison across trials. The THI has been chosen as
comparator, because it is easily applicable, most widely used, and most
widely translated (Langguth et al., 2007).
A higher level of standardization of clinical trial methodology has been
achieved with the establishment of the TRI database (Landgrebe et al.,
2010). Performing clinical trials according to standardized methodology
and pooling the data in a database should facilitate both clinical subtypization
of different forms of tinnitus, and identification of promising treatments for
different types of tinnitus. This would be an important step toward the goal of
individualized treatment of tinnitus.
In order to standardize and improve the clinical management of
tinnitus patients, a project for developing an algorithm for diagnostic and
therapeutic management of tinnitus has been initiated. As pointed out in
the commentary of Searchfield, this project is intended to be a living
and growing document and is in its current form available at the TRI
website (http://www.tinnitusresearch.org/en/projects/flowchart_en.php).
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Asmentioned correctly byHoare et al. the TRI algorithm is based on amed-
ical model. The algorithm has been developed by a multidisciplinary team
involving otolaryngologists, neuro-otologists, audiologists, neurologists, psy-
chiatrists, and a neurosurgeon. It is characterized by the belief that tinnitus is a
symptom that can result from of a large variety of different underlying pathol-
ogies. Considering the facts that some of these pathologies can be life threaten-
ing, if left untreated (e.g., carotid dissection, acousticus neurinoma,
suicidality), and that some of the underlying pathologies can be causally
treated (e.g., ear wax, microvascular compression), we strongly advocate a
comprehensivemedical diagnosticworkupofevery tinnituspatient as thebasis
for all therapeutic decisions—similar like in most other areas of medicine.
We consider it as inappropriate and dangerous to recommend self-
management without diagnosis.
We agreewithHoare et al. that clear links between results from diagnostic
tests and therapeutic recommendation would be desirable. In the development
of the TRI algorithm, we try to provide guidance about indications for
advanced diagnostic tests and therapeutic interventions based on the findings
in the basic assessment. Currently, there are only low levels of evidence for
establishingmost of these links, indicating the need for further research efforts.
We also want to further underscore Searchfield’s position to include
recommendations with low evidence levels in a flowchart. Evidence based
on clinical studies and clinical relevance for the treatment of the individual
patient are not identical. If a specific intervention has been demonstrated
to have a small benefit in several controlled studies involving large samples,
it is considered the highest level of evidence. However, this small benefit
may be clinically completely irrelevant in a specific patient. In contrast, if
an intervention has been shown to stop tinnitus in case series of a specific rare
subform of tinnitus (e.g., carbamazepine treatment in ‘‘type-writer-tinnitus’’),
it is only considered as a recommendation of relative low evidence, but it has
a huge clinical relevance for the affected patient.
Thus, we agree to the need of more standardization in tinnitus research
and treatment. At the same time we advocate the development of different
standardization approaches for the different purposes clinical research and
patientmanagement. In viewof the complexity of tinnitus, these are challenging
tasks that will require a step-wise approach.
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